HomeNewsBusinessFMCG firms brace for third wave of Covid-19

FMCG firms brace for third wave of Covid-19

ITC, Parle Products, Bikanervala Foods and Prataap Snacks are strengthening their supply-chains to ensure there is no disruption in the event of restrictions due to a third wave of the pandemic.

January 03, 2022 / 16:49 IST
Story continues below Advertisement
FMCG companies believe that their learnings from the past two experiences will help them tide over a third wave of the pandemic.
FMCG companies believe that their learnings from the past two experiences will help them tide over a third wave of the pandemic.

With Covid-19 cases on the rise in India, consumer goods companies, especially those offering food products, are gearing up for a possible third wave of the pandemic.

ITC, Parle Products, Bikanervala Foods, and Prataap Snacks are stocking up on their products, increasing their focus on e-commerce, and even launching larger pack sizes, expecting a surge in at-home consumption in the event of tighter restrictions or a lockdown. The companies are confident of tiding over a third wave after the experience of the past two years.

Story continues below Advertisement

Learnings from 2020

“The ITC supply chain – given our experience of the first two waves, the robust SOPs created as a result of the same and having adequate inventory across various nodes in multiple geographies – is now in a much better position to address any challenges arising because of any restrictions,” an ITC spokesperson said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show